NASDAQ:OMCL - Omnicell Stock Price, News & Analysis

Omnicell trades on the NASDAQ under the ticker symbol "OMCL."

Omnicell, Inc. (NASDAQ:OMCL) released its quarterly earnings results on Thursday, July, 25th. The company reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.47 by $0.04. The business earned $217.40 million during the quarter, compared to the consensus estimate of $214.13 million. Omnicell had a return on equity of 11.85% and a net margin of 5.70%. The business's revenue was up 15.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.46 EPS. View Omnicell's Earnings History.

Omnicell is scheduled to release their next quarterly earnings announcement on Thursday, October 24th 2019. View Earnings Estimates for Omnicell.

Omnicell issued an update on its FY19 earnings guidance on Thursday, July, 25th. The company provided EPS guidance of $2.65-$2.82 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.77. The company issued revenue guidance of $886-$900 million, compared to the consensus revenue estimate of $891.96 million.

7 equities research analysts have issued twelve-month price targets for Omnicell's shares. Their predictions range from $61.00 to $90.00. On average, they anticipate Omnicell's stock price to reach $80.2857 in the next year. This suggests a possible upside of 8.9% from the stock's current price. View Analyst Price Targets for Omnicell.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Omnicell in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Omnicell.

Press coverage about OMCL stock has trended somewhat positive this week, according to InfoTrie Sentiment. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Omnicell earned a daily sentiment score of 0.9 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Omnicell.

Some companies that are related to Omnicell include Nice (NICE), CAPCOM CO LTD/ADR (CCOEY), Teradata (TDC), Cray (CRAY), Fitbit (FIT), Super Micro Computer (SMCI), Huami (HMI), One Stop Systems (OSS), CCUR (CCUR) and Socket Mobile (SCKT).

Based on aggregate information from My MarketBeat watchlists, some companies that other Omnicell investors own include Johnson & Johnson (jnj), AT&T (T), AbbVie (ABBV), Gilead Sciences (GILD), Micron Technology (MU), Adobe (ADBE), Netflix (NFLX), NVIDIA (NVDA), Paypal (PYPL) and QUALCOMM (QCOM).

Omnicell's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (15.40%), BlackRock Inc. (15.40%), Vanguard Group Inc. (10.14%), Conestoga Capital Advisors LLC (3.82%), Eagle Asset Management Inc. (2.02%) and Invesco Ltd. (1.87%). Company insiders that own Omnicell stock include Dan S Johnston, Gary S Petersmeyer, James T Judson, Joanne B Bauer, Jorge R Taborga, Joseph Brian Spears, Nhat H Ngo, Peter J Kuipers, Randall A Lipps, Robin Gene Seim and Scott Peter Seidelmann. View Institutional Ownership Trends for Omnicell.

OMCL stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, First Light Asset Management LLC, WINTON GROUP Ltd, Carillon Tower Advisers Inc., Eagle Asset Management Inc., Natixis, Natixis and Kornitzer Capital Management Inc. KS. Company insiders that have sold Omnicell company stock in the last year include Dan S Johnston, Gary S Petersmeyer, James T Judson, Joanne B Bauer, Jorge R Taborga, Joseph Brian Spears, Nhat H Ngo, Peter J Kuipers, Randall A Lipps and Scott Peter Seidelmann. View Insider Buying and Selling for Omnicell.

OMCL stock was acquired by a variety of institutional investors in the last quarter, including Invesco Ltd., BlackRock Inc., BlackRock Inc., Nuveen Asset Management LLC, Vanguard Group Inc., Allianz Asset Management GmbH, Morgan Stanley and Charles Schwab Investment Management Inc.. View Insider Buying and Selling for Omnicell.

Shares of OMCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of OMCL stock can currently be purchased for approximately $73.72.

Omnicell has a market capitalization of $3.07 billion and generates $787.31 million in revenue each year. The company earns $37.73 million in net income (profit) each year or $1.53 on an earnings per share basis. Omnicell employs 2,480 workers across the globe.View Additional Information About Omnicell.

The official website for Omnicell is http://www.omnicell.com/.

Omnicell's mailing address is 590 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. The company can be reached via phone at 650-251-6100 or via email at [email protected]